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Abstract
Background: Socio-economic status from early life has been linked to cardiovascular
disease risk, but the impact of life-course socio-economic trajectories, as well as the
mechanisms underlying social inequalities in cardiovascular disease risk, is uncertain.
Objectives:We assessed the role of behavioural, psychosocial and physiological (includ-
ing inflammatory) factors in the association between life-course socio-economic status
and cardiovascular disease mortality in older adults.
Methods: Participants were 7846 individuals (44% women) from the English Longitudinal
Study of Ageing, a representative study of individuals aged50 years, established in
2002–03. Comprising four indicators of socio-economic status (father’s social class, own
education, occupational position and wealth), we computed an index of socio-economic
trajectory and a lifetime cumulative socio-economic score. Behavioural (smoking, phys-
ical activity, alcohol consumption, body mass index) and psychosocial (social relations,
loneliness) factors, physiological (blood pressure, total cholesterol, triglycerides) and in-
flammatory markers (C-reactive protein, fibrinogen), measured repeatedly over time,
were potential explanatory variables. Cardiovascular disease mortality was ascertained
by linkage of study members to a national mortality register. Mediation was calculated
using the traditional ‘change-in-estimate method’ and alternative approaches such as
counterfactual mediation modelling could not be applied in this context.
Results: During the 8.4-year follow-up, 1301 study members died (438 from cardiovascu-
lar disease). A stable low-social-class trajectory was associated with around double the
risk of cardiovascular disease mortality (hazard ratio; 95% confidence interval: 1.94, 1.37;
2.75) compared with a stable high social class across the life course. Individuals in the
lowest relative to the highest life-course cumulative socio-economic status group were
also more than twice as likely to die of cardiovascular disease (2.57, 1.81; 3.65).
Behavioural factors and inflammatory markers contributed most to explaining this
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gradient, whereas the role of psychosocial and other physiological risk factors was
modest.
Conclusions: In a population-based cohort of older individuals living in England, we pro-
vide evidence that disadvantage across the life course is linked to cardiovascular mortal-
ity. That behavioural factors and inflammatory markers partially explain this gradient
may provide insights into the potential for intervention.
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Introduction
Cardiovascular disease is a leading cause of death world-
wide.1 It is now well established that, in high-income coun-
tries, the occurrence of cardiovascular disease (CVD) is
greatest among individuals in poorer socio-economic cir-
cumstances.2–4 Socio-economic differentials also appear to
have their origins in early life,5–12 and possibly even in
prior generations. As highlighted in a recent position state-
ment of the American Heart Association13 and other
reviews,14 however, studies exploring the influence of life-
course socio-economic status (SES) on CVD are very rare.
Moreover, the few existent studies sample middle-aged
populations, so whether life-course SES still exerts an im-
pact on CVD mortality at older ages, when the burden of
CVD is at its greatest, remains unknown.
Explaining socio-economic inequalities in CVD is key
to the implementation of effective policies to reduce
them,13 yet the physiological mechanisms underlying social
inequalities in CVD at older ages are not well understood.
Whereas it has been suggested that the association between
life-course SES and adult chronic diseases may be ex-
plained, at least in part, by chronic inflammation,15 to the
best of our knowledge, the contribution of inflammation
to social inequalities in CVD mortality has yet to be
examined.
At least three conceptual models describe the impact of
life-course socio-economic circumstances on health in
adulthood: (i) latent effects of early-life socio-economic cir-
cumstances on adult health; (ii) cumulative effect of expos-
ure to adverse socio-economic circumstances from across
the life course that affect health in a dose–response
manner; and (iii) pathways effects of early-life socio-eco-
nomic circumstances on individuals’ trajectories to SES in
adulthood, that in turn have an impact on health.16,17
In a well-characterized study of individuals aged 50 years
or older at study induction—the English Longitudinal Study
on Ageing (ELSA)—our main objective was to assess the in-
fluence of life-course social trajectories on CVD risk.
However, to address all the three conceptual models,
we also compare different indicators of SES over the life
course, as well as assess the impact of cumulative exposure
to low SES across the life course for their effect on CVD
mortality.
We also examine the potential mediator effect of in-
flammatory markers in the relationship between SES and
risk of CVD, placing their role in context by comparing
them with classic behavioural and psychosocial risk
factors.
Data and methods
Study population
The ELSA is an ongoing, prospective cohort study of
community-dwelling older people. Described in detail else-
where,18 ELSA was established in 2002–03 with a core
sample of 11 391 women and men aged 50 years and over.
It is representative of the national population in this age
range living in private addresses in England.18 Participants
have been contacted every 2 years for an interview and
every 4 years for a medical examination. For the present
analysis, ‘baseline’ was fixed at the ELSA wave 2 (2004/5)
when biological data were first collected (N¼ 8688).
Key Messages
• The impact of life-course socio-economic trajectories on cardiovascular disease morbidity and mortality is uncertain.
• In this study, low socio-economic status across the life course was strongly associated with a higher risk of cardio-
vascular mortality.
• Behavioural factors and inflammatory markers appeared to explain a relatively large proportion of this association,
providing insights into the potentials for intervention.
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Socio-economic factors
We used two indicators of life-course SES: a measure of
life-course socio-economic trajectories and a cumulative
life-course SES index. The trajectories index was computed
using two socio-economic indicators chosen because they
had the same scoring structure: paternal occupational social
class (i.e. SES of origin) and study participant’s own occu-
pational social class (i.e. attained SES). Paternal occupa-
tional social class was categorized as high (managerial,
professional and administrative occupations or business
owners), intermediate (trade and services related occupa-
tions) and low (manual and casual occupations and other
occupations). Participants’ own occupational position was
measured using the three-class version of the National
Statistics—Socioeconomic Classification Scheme19 and was
categorized as high (managerial and professional occupa-
tions), intermediate (intermediate occupations) and low
(semi-routine and routine occupations). Participants who
had never worked (n¼ 108) or were of unknown occupa-
tional status (n¼ 1) were excluded from the analyses. These
participants tended to be older and had a lower educational
level. However, given their very small number in relation to
the total population (1%), it is unlikely that their exclusion
has biased our results. This resulted in four combinations of
possible occupational social class trajectories across the life
course: ‘stable high’ (high paternal occupation and own oc-
cupation), ‘upward’ (low or intermediate paternal occupa-
tion and high own occupation), ‘downward’ (high or
intermediate paternal occupation and low own occupation)
and ‘stable low’ (low paternal occupation and own
occupation).
A cumulative life-course SES status index was computed
using information on four socio-economic indicators: pa-
ternal occupational position and participant’s own occupa-
tional position (described above) plus education, an
indicator of SES in young adulthood, and wealth, meas-
ured at study induction and thus representing SES in early
old life. Education was categorized according to the age at
which participants finished full-time education [high (17
years), intermediate (15–16 years) and low ( 14 years or
no education)]. Wealth, i.e. total net non-pension house-
hold wealth, was grouped into tertiles and based on an esti-
mation of the assets of study members and their partners,
including properties, businesses, other assets and any form
of investments or savings (except for pension savings) less
debts owed by them. The four individual SES indicators
were each coded as 0–2, with higher values indicating
greater disadvantage. To compute a cumulative life-course
SES index, the four SES indicators were summed, resulting
in a nine-value variable, with higher values again corres-
ponding to greater life-course disadvantage.
Behavioural factors
Smoking status was self-reported and classified as current,
former, never smoker. Leisure-time physical activity was
assessed by asking participants how often they engaged in
vigorous, moderate or mild physical activity. Three groups
were then created: active (once/week), moderately active
(one to three times/month) and inactive (hardly ever/
never). Frequency of alcohol intake was self-reported and
classified as less than daily or daily consumption. Height
and weight were measured directly using standard proced-
ures, and body mass index (BMI) then computed as weight
in kilograms divided by the square of height in metres.20
Psychosocial factors
The self-completion questionnaire included a series of de-
tailed items on the quality of the respondents’ social rela-
tionships, social networks and loneliness.21 Specifically,
respondents were asked about the presence of support
(positive/negative) from their spouse and children.
Responses to positive and negative support items were
summed to create positive aspects of social relations scale
(total score ranges from 0 to 9, with higher scores indicat-
ing greater positive support) and negative aspects of social
relations scale (total score ranges from 0 to 9, with higher
scores indicating greater negative support).22 Only positive
and negative support scores from the spouse were included
in the present study. Low positive support was represented
by the lowest tertile and high negative support as the high-
est tertile.
Respondents were also asked to indicate the number of
family members and friends with whom they had a close
relationship. From this question, a continuous variable was
derived that indicated the number of close friends or family
in the respondents’ social networks. High social network
size was defined as the highest tertile. Loneliness was meas-
ured using an abridged version23 of the 20-item Revised
UCLA loneliness scale.24 The dimensions of loneliness that
this scale measures are self-perceived isolation, and rela-
tional and social connectedness. A summary score was cre-
ated by summing up the responses on three of the items;
the total score ranged from 0 to 6, with higher scores indi-
cating greater perceived loneliness. High loneliness was
represented by the highest tertile.
Physiological factors
During study waves 2 (2004/5) and 4 (2008/9), a nurse
measured systolic (SBP) and diastolic blood pressure (DBP)
(Omron HEM 907) on three occasions at 1-minute inter-
vals with the subjects seated; SBP and DBP are derived
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as the mean of the first two readings. Hypertension
was considered as SBP140 or DBP 90 or taking
anti-hypertensive drugs, whereas normotension was taken
as SBP< 120 and DBP< 80. A blood sample was also
drawn from consenting respondents in order to measure
levels of fibrinogen, total cholesterol, triglycerides and
C-reactive protein. High total cholesterol was defined
for values 5.2 mmol/l and high triglycerides for val-
ues> 1.7 mmol/l.
High-sensitivity C-reactive protein (CRP) was analysed
using the N Latex CRP mono Immunoassay on the Behring
Nephelometer II Analyzer (Dade Behring, Milton Keynes,
UK). In all analyses, CRP data, originally skewed, were
normalized using log-transformation. Fibrinogen levels
were ascertained using a modification of the Clauss throm-
bin clotting method on the Organon Teknika MDA 180
analyser. High CRP and high fibrinogen were represented
by the highest tertiles of their distribution.
Prevalent chronic illness (coronary heart disease, stroke
and/or cancer) at baseline, as well as age and sex, were
considered as confounding factors in all analyses.
Mortality ascertainment
Study members were linked to the National Health
Service’s Central Registry at Southport, UK, the procedures
of which provide vital status data and, where applicable,
cause of death. CVD death was coded according to
International Classification of Disease chapters (version
10, codes I00–I99). Follow-up began on the date of study
baseline (2004/5), with study members censored at date of
death or end of follow-up (February 2013)—whichever
came first.
Statistical analysis
Missing values for risk factors were replaced using infor-
mation collected at the previous or successive wave. For
those study members without information available at ad-
jacent waves, multivariable imputation based on sex, age,
ethnicity and lifestyle factors (Stata uvis procedure) was
used. Missing values for the exposures (SES) and outcomes
(CVD mortality) of interest were not imputed. Sensitivity
analysis restricted to participants with no missing data
yielded similar results to those presented here. Having as-
certained that the proportional hazard assumption had not
been violated, Cox regressions were used to compute haz-
ard ratios (HRs) with accompanying 95% confidence
intervals (CIs) for the association between life-course SES
and mortality. With no evidence of effect modification by
sex, data were pooled and sex-adjusted. Life-course SES
trajectory was treated as a categorical variable (p for linear
trend¼ 0.121). The life-course cumulative SES score was
entered into the models as a continuous variable (p for lin-
ear trend¼ 0.014) and HRs are calculated for the highest
vs the lowest category.25 Each life-course SES indicator
was first entered into a basic model containing age, sex
and prevalent disease conditions (Model 1). Then, behav-
ioural factors, psychosocial factors, physiological factors
and inflammatory markers (time-dependent covariates
updated at waves 2 and 4) were added first individually
and then simultaneously to the multivariable model. All
covariates were entered as continuous variables, apart
from smoking, physical activity and alcohol consumption.
To account for long-term exposure to these risk factors, at
each follow-up period, we controlled not only for the risk
factor at the current wave, but also for the risk factors at
previous waves, as we have previously.15 The contribution
of risk factors to explaining the SES–mortality association
was determined by the percent attenuation in the b coeffi-
cient for SES after inclusion of the risk factor in question
to Model 1 (age and sex): ‘100 (bModel 1 – bModel 1þ risk
factor(s))/(bModel 1)’. We calculated a 95% CI around the
percentage attenuation using a bootstrap method with
1000 re-samplings. All analyses were conducted using
Stata (version 13.1, Stata Corp, College Station, TX, USA).
Results
A total of 8688 participants provided data at the baseline
for the present analyses. Of these, 842 (9%) were excluded
because of missing values for socio-economic indicators
(N¼ 143), behavioural factors (N¼ 276), psychosocial
factors (N¼ 17), physiological factors (N¼ 267) or inflam-
matory markers (N¼ 399) (categories are not mutually ex-
clusive). Relative to study members included in the present
analyses, those excluded were somewhat older (69.4 vs
65.9 years, p< .001) and were more likely to come from a
disadvantaged socio-economic background (26% vs 22%
from a ‘stable low’ SES trajectory, p< 0.001). Whereas
these absolute differences were not considerable, they at-
tained statistical significance owing to the large study
numbers.
Table 1 shows the baseline characteristics of the sample
according to occupational social class trajectories from
childhood to adulthood. In general, study members whose
father was from a low occupational group and those who
also remained in this group as adults (‘stable low’) had the
least favourable risk factor profile, such that there was a
marked gradient in behavioural, psychological, physio-
logical and inflammatory factors at baseline. In particular,
relative to the ‘stable high’ group, people in the ‘stable
low’ category were three times more likely to smoke cigar-
ettes, twice as likely to be sedentary and have higher levels
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of systolic blood pressure, CRP and fibrinogen (p< 0.001).
Whereas statistically significant differences were apparent
for other characteristics, absolute differences between
these groups were modest. In one of the few exceptions to
the general unfavourable risk factor profile, people in the
stable low category were less likely to consume alcohol
frequently.
A total of 1301 participants died during the 8.4-year
follow-up, 438 from CVD. HRs (95% CI) for the associ-
ation of individual behavioural, psychosocial, physio-
logical and inflammatory risk factors at baseline and CVD
mortality are shown in Table 2. For the purposes of com-
parison, here and throughout our analyses, we also include
results for total mortality. As anticipated, smoking (HR;
95% CI: 2.01, 1.54; 2.63) and physical inactivity (2.64,
2.15; 3.24) were associated with CVD mortality, as well as
loneliness (1.44, 1.19; 1.74) and small network size (1.31,
1.08; 1.57). High total cholesterol was related to lower
CVD mortality risk (HR, 95% CI: 0.71, 0.58; 0.86),
whereas high fibrinogen and CRP levels were related to
higher CVD mortality risk (HR, 95% CI: 1.74, 1.44; 2.09
for high vs low CRP tertile). Alcohol consumption, obesity,
positive support score, hypertension and triglycerides levels
were not related to mortality. Results for all-cause mortal-
ity were similar to those for CVD mortality.
Table 3 and Figure 1 show results for the association of
life-course social trajectories with total and CVD mortality.
We also show the relative contribution of different explana-
tory risk factors to this association. In analyses featuring
CVD death as the endpoint of interest, a stable low social
class was associated with 94% higher risk (95% CI: 1.37;
2.75) as compared with a stable high social class. Upwardly
and downwardly mobile individuals also experienced a
higher risk of mortality for CVD but these effects were not
statistically significant at conventional levels. All risk fac-
tors combined explained 37% of the association between
stable low social trajectory and CVD mortality (95% CI: 7,
94), most of the contribution being from behavioural fac-
tors (24%, 95% CI: 3; 67) and inflammatory markers
(16%, 95% CI: 6; 38). Results for total mortality were
similar to those for CVD mortality, although the HRs were
of lower magnitude. All risk factors combined explained
62% of the association between stable low social trajectory
and total mortality (95% CI: 26; 159).
Table 1. Study participant characteristics at baseline according to life-course occupational social class trajectories—the English
Longitudinal Study of Ageing (N¼7846)
Life-course social trajectoriesa Total
Stable high Upward Downward Stable low Pb
N (%) 1084 (13.8) 2697 (34.4) 2439 (31.1) 1626 (20.7) 7846
Age 65.3 (9.5) 65.9 (9.5) 66.9 (9.7) 67.1 (9.6) <0.001 66.4 (9.6)
Men, N (%) 508 (46.9) (481) 1389 (51.5) 1494 (61.3) 900 (55.4) <0.001 4291 (54.7)
CVD mortality (N, ratec) 42 (5.1) 136 (6.0) 130 (6.4) 130 (9.8) 0.121 438 (6.7)
Behavioural factors
Current smoking, N (%) 79 (7.3) 352 (13.1) 388 (15.9) 347 (21.3) <0.001 1166 (14.9)
Physical inactivity, N (%) 98 (9.0) 358 (13.3) 411 (16.9) 370 (22.8) <0.001 1237 (15.8)
Daily alcohol consumption, N (%) 409 (37.8) 681 (25.3) 510 (21.9) 254 (15.6) <0.001 1854 (23.6)
BMI 27.1 (4.7) 27.8 (4.7) 27.9 (4.7) 28.8 (5.3) <0.001 27.9 (4.9)
Psychosocial factors
Loneliness score 0.84 (1.3) 1.04 (1.5) 1.24 (1.6) 1.42 (1.7) <0.001 1.14 (1.5)
Social network size 8.78 (5.6) 8.54 (5.9) 8.66 (5.9) 8.35 (5.9) 0.146 8.57 (5.8)
Positive support score 7.88 (1.7) 7.86 (1.7) 7.74 (1.9) 7.70 (1.8) 0.001 7.80 (1.8)
Negative support score 2.29 (1.7) 2.38 (1.7) 2.51 (1.9) 2.48 (1.8) 0.001 2.43 (1.8)
Physiological factors
Systolic blood pressure (mmHg) 133.1 (18.2) 134.9 (18.7) 135.6 (9.0) 136.2 (18.9) <0.001 135.0 (18.7)
DBP (mmHg) 74.6 (11.0) 75.2 (11.4) 74.6 (11.0) 74.4 (11.3) 0.110 74.8 (11.2)
Total cholesterol (mmol/l) 5.95 (1.2) 5.82 (1.2) 5.85 (1.2) 5.74 (1.2) <0.001 5.83 (1.2)
Triglycerides (mmol/l) 1.70 (1.1) 1.81 (1.1) 1.82 (1.2) 1.95 (1.2) <0.001 1.83 (1.2)
Inflammatory markers
CRP (mg/l) 3.39 (7.6) 4.10 (8.4) 4.35 (7.8) 4.93 (8.9) <0.001 4.25 (8.2)
Fibrinogen (g/l) 3.09 (0.6) 3.23 (0.7) 3.27 (0.7) 3.33 (0.7) <0.001 3.25 (0.7)
Results are mean (SD) unless otherwise reported.
aLife-course social trajectories are based on trajectories from father’s occupational position to the participants’ own occupational class.
bp for linear trend across socio-economic categories.
cAge and sex-adjusted mortality rate per 1000 person-years.
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Results for the association of life-course cumulative SES
score with mortality are shown in Table 4 and Figure 1.
Individuals with a low relative to high life-course cumula-
tive SES score were 87% (95% CI: 1.40; 2.15) and 157%
(95% CI: 1.66; 3.54) more likely to die of total or CVD
mortality, respectively. As apparent for the analyses of life-
course social trajectories and CVD mortality, of the study
covariates, behavioural factors (38%) and inflammatory
(18%) markers appeared to explain most of this gradient.
Adjustment for all risk factors simultaneously attenuated
the HR for lowest vs highest cumulative SES score by 55%
(95% CI: 27; 104) for CVD mortality. Similar results were
apparent when total mortality was the outcome of interest.
Associations between the four individual SES indicators
and mortality are shown in supplementary materials, avail-
able as Supplementary Data at IJE online. Low father’s social
class (Supplementary Table 1, available as Supplementary
Data at IJE online), low education (Supplementary Table 2,
available as Supplementary Data at IJE online), low
adult social class (Supplementary Table 3, available as
Supplementary Data at IJE online) and low adult wealth
(Supplementary Table 4, available as Supplementary Data at
IJE online) were related to higher total and CVD mortality
risk. All risk factors combined explained between 62 and
85% of the SES gradient in total mortality, with correspond-
ing values of 40–66% for CVD mortality. As per the analyses
of these SES indices in combination, most of the explanatory
contributions came from behavioural factors and inflamma-
tory markers. Finally, we conducted additional sensitivity
analyses to assess whether an existing acute infection at study
induction altered our results. To do so, we repeated our ana-
lyses of cumulative SES score and CVD mortality after an in-
cremental exclusion of people with raised CRP levels
(Supplementary Table 5, available as Supplementary Data at
IJE online). Our overall conclusions were unchanged; if any-
thing, the SES-CVD relation strengthened the lower the CRP
levels at which exclusions of study members took place.
Formal tests did not reveal a significantly different ef-
fect by age group (p for interaction between age group and
life-course SES¼ 0.404), although, in sensitivity analyses
stratified by age group (65 years and >65 years,
Supplementary Table 8, available as Supplementary Data
at IJE online), the association between life-course SES indi-
cators and CVD mortality tended to be somewhat stronger
in the younger compared with the older age group.
Discussion
Our main finding was that, in a population of older people,
SES across the life course was a strong predictor of CVD
mortality, such that individuals who had a stable low
socio-economic trajectory or were cumulatively exposed to
poor socio-economic circumstances from childhood to adult-
hood experienced the greatest risk. Moreover, we showed
that up to half of the socio-economic gradient in CVD mor-
tality was explained by socio-economic variations in behav-
ioural, psychosocial, physiological and inflammatory risk
Table 2. HRs (95% CI) for the association of risk factors at
baseline with total and CVD mortality (N¼ 7846)—the English
Longitudinal Study of Ageing
Total mortality CVD mortality
Deaths 1301 438
Behavioural factors
Smoking
Never/Former 1.00 (ref) 1.00 (ref)
Current smoker 2.10 (1.82; 2.43) 2.01 (1.54; 2.63)
Physical activity
Active/ Moderately
active
1.00 1.00
Inactive 2.19 (1.94; 2.47) 2.64 (2.15; 3.24)
Alcohol consumption
Less than daily 1.00 1.00
Daily 0.98 (0.86; 1.11) 1.00 (0.80; 1.25)
BMI
<30 kg/m2 1.00 1.00
30 kg/m2 1.09 (0.97; 1.23) 1.21 (0.98; 1.49)
Psychosocial factors
Loneliness score
Low 1.00 1.00
High 1.23 (1.10; 1.38) 1.44 (1.19; 1.74)
Social network size
Large 1.00 1.00
Small 1.23 (1.10; 1.37) 1.31 (1.08; 1.57)
Positive support score
High 1.00 1.00
Low 1.13 (1.01; 1.26) 1.13 (0.93; 1.36)
Negative support score
Low 1.00 1.00
High 1.12 (0.99; 1.28) 1.13 (0.90; 1.42)
Physiological factors
Blood pressure
Normotensive 1.00 1.00
Hypertensive 1.00 (0.94; 1.08) 1.06 (0.96; 1.19)
Total cholesterol level
Low 1.00 1.00
High 0.80 (0.71; 0.90) 0.71 (0.58; 0.86)
Triglycerides level
Low 1.00 1.00
High 1.00 (0.90; 1.12) 1.01 (0.84; 1.23)
Inflammatory markers
Fibrinogen level
Low 1.00 1.00
High 1.38 (1.24; 1.54) 1.53 (1.26; 1.85)
CRP level
Low 1.00 1.00
High 1.57 (1.41; 1.75) 1.74 (1.44; 2.09)
CVD, cardiovascular disease; SD, standard deviation; SBP, systolic blood
pressure; DBP, diastolic blood pressure.
High CRP and high fibrinogen were represented by the highest tertiles of
their distribution.
aHazard ratios adjusted for age, sex and prevalent conditions at baseline.
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factors, the major contribution being from behavioural fac-
tors and inflammatory markers. To our knowledge, our
study represents the first evidence of a contribution of in-
flammation to life-course social differences in mortality.
In this study, we used two indicators of life-course SES:
a measure of social trajectories from childhood to adult-
hood and a summary measure of four individual socio-
economic indicators spanning across the lifetime (father’s
social class, education, occupational position and wealth).
We showed that individuals who were in the low SES
group across the life course had a greater mortality risk
than those people who were in the higher SES category
throughout this period. As our study focuses on older ages,
comparing with previous studies, we choose to compute a
life-course SES score using four indicators from early life
to early old age. We found that the longer the duration of
exposure to disadvantaged SES, the higher the CVD
mortality risk, supporting the accumulation hypothesis of
disease risk across the life course.16,26
A systematic review that evaluated the evidence for
models of life-course socio-economic factors and cardio-
vascular outcomes concluded that there is little support for
a unique influence of social mobility on CVD risk.26 In
addition, a recent scientific statement from the American
Heart Association on the social determinants of risk and
outcomes for cardiovascular disease concluded that evi-
dence on the role of upward or downward socio-economic
mobility in generating CVD differences is limited.13 In our
study, although individuals with an upward or downward
social trajectory had a slightly higher mortality risk than
those with a ‘stable high’ trajectory, this was not statistically
significant at conventional levels. This result supports the
‘health constraint’ hypothesis according to which socially
mobile individuals possess health characteristics of both the
Table 3. HRs (95% CI) for the association of life-course social trajectories with total and CVD mortality—the English Longitudinal
Study of Ageing (N¼7846)
Life-course social trajectories
Stable high Upward Downward Stable low
Total mortality (1301 deaths) HR (95% CI) HR (95% CI) %D HR (95% CI) %D HR (95% CI) %D (95% CI)
Model 1: Age, sex, & health conditions 1.00 (ref) 1.17 (0.97; 1.40) 1.17 (0.97; 1.42) 1.45 (1.20; 1.76)
Model 2: Model 1þ behavioural factors 1.00 1.12 (0.93; 1.36) – 1.05 (0.87; 1.28) – 1.23 (1.01; 1.51) –43 (–120; –17)
Model 3: Model 1þ psychosocial factors 1.00 1.15 (0.95; 1.39) – 1.14 (0.94; 1.39) – 1.39 (1.14; 1.69) –11 (–42; –4)
Model 4: Model 1þ physiological factors 1.00 1.15 (0.95; 1.39) – 1.15 (0.95; 1.39) – 1.41 (1.15; 1.71) –8 (–38; –1)
Model 5: Model 1þ inflammatory markers 1.00 1.09 (0.91; 1.32) – 1.07 (0.87; 1.30) – 1.31 (1.08; 1.60) –27 (–70; –11)
Model 6: Model 1þ all risk factors 1.00 1.06 (0.88; 1.29) – 0.99 (0.81; 1.20) – 1.15 (0.94; 1.40) –62 (–159; –26)
CVD mortality (438 deaths)
Model 1: Age, sex, & health conditions 1.00 1.29 (0.92; 1.82) 1.25 (0.88; 1.77) 1.94 (1.37; 2.75)
Model 2: Model 1þ behavioural factors 1.00 1.25 (0.88; 1.77) – 1.13 (0.79; 1.61) – 1.65 (1.16; 2.36) –24 (–67; –3)
Model 3: Model 1þ psychosocial factors 1.00 1.27 (0.90; 1.80) – 1.22 (0.86; 1.72) – 1.85 (1.30; 2.73) –7 (–23; 1)
Model 4: Model 1þ physiological factors 1.00 1.25 (0.88; 1.77) – 1.21 (0.85; 1.71) – 1.81 (1.27; 2.57) –11 (–39; –2)
Model 5: Model 1þ inflammatory markers 1.00 1.21 (0.85; 1.71) – 1.13 (0.80; 1.61) – 1.75 (1.23; 2.47) –16 (–38; –6)
Model 6: Model 1þ all risk factors 1.00 1.17 (0.82; 1.76) – 1.05 (0.73; 1.50) – 1.51 (1.05; 2.17) –37 (–94; –7)
CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio; D, attenuation, representing the proportion of the SES–mortality association explained
by the risk factor in question. % attenuation is calculated only for statistically significant associations.
Behavioural factors include current smoking, physical activity, alcohol consumption and BMI; psychosocial factors include loneliness score, social network
size, negative and positive support from spouse; physiological factors include systolic and DBP, cholesterol and triglycerides levels; inflammatory markers include
CRP and fibrinogen.
Figure 1. Association of life-course SES trajectory (A) and life-course cumulative SES score (B) with CVD mortality.
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SES group that they leave and the one that they join, placing
them at an intermediate risk.27 This has been reported in
other studies focusing on younger populations.26,28–30
We examine the contribution of several factors to the as-
sociation between life-course SES and CVD mortality.
Existing studies have shown that behavioural factors are
major contributors to the association between adult SES and
mortality, at least in populations with a strong social pat-
terning of these behaviours.25,31,32 Our study confirms that
this is also the case for life-course SES in older populations,
although the proportion of the gradient explained by behav-
ioural factors seemed to be lower than in studies focusing on
adult SES.25,32 Even in our study, behavioural factors ex-
plained a larger proportion of the association of adult SES
with mortality than that seen for early-life SES. This may be
related to the fact that we captured health behaviours cov-
ered in older age as opposed to earlier in the life course.
Comparison with existing studies
Our study pointed to a role for chronic inflammation in ex-
plaining social differences in total and CVD mortality.
Recent evidence suggests that individuals who experience
early-life socio-economic adversity are characterized by
exaggerated inflammatory responses that potentially put
them at increased risk of inflammation-related diseases in
later life.33,34 In a report in the British Whitehall II study,
chronic inflammation explained about one-third of the
association between life-course SES and the incidence of
type 2 diabetes.15 Life-course socio-economic differences
in chronic inflammation may be related to, first, the impact
of exposure to adversity in early life on the regulation of
the inflammatory response33 and, second, to insults across
the life course that are themselves related to inflammation,
such as chronic stress or health-risk behaviours.35–38
Further research is needed to disentangle the impact of
different exposures across the life course on chronic
inflammation.
In our study, psychosocial and physiological factors,
such as social relations, blood pressure, total cholesterol
and triglycerides, contributed little to life-course socio-eco-
nomic differentials in total and CVD mortality. This was
to be expected given their weaker associations than those
evident for behavioural factors and inflammatory markers.
Estimates for the contribution of psychosocial factors to
social inequalities in mortality vary across studies,39–43
partly because studies generally differ in the type of psy-
chosocial factors assessed, so rendering any comparison
problematic.
In our study, blood cholesterol concentration was slightly
higher in the higher SES group, as commonly observed in
England.44 Further, high cholesterol was protective against
total and CVD mortality in our sample. This may in part be
related to our failure to account for cholesterol-lowering
drugs, information on which was not collected in the present
study. On the other hand, there is evidence that total
Table 4. HRs (95% CI) for the association of life-course cumulative socio-economic score with total and CVD mortality—the
English Longitudinal Study of Ageing (N¼7846)
Life-course cumulative SES scorea
HR (95% CI) %D (95% CI)
Total mortality (1301 deaths)
Model 1: Age, sex and health conditions 1.87 (1.53; 2.28)
Model 2: Model 1þbehavioural factors 1.35 (1.09; 1.66) –52 (–93; –31)
Model 3: Model 1þpsychosocial factors 1.74 (1.42; 2.13) –11 (–29; –7)
Model 4: Model 1þphysiological factors 1.78 (1.45; 2.18) –7 (–24; –2)
Model 5: Model 1þ inflammatory markers 1.59 (1.29; 1.94) –26 (–38; –12)
Model 6: Model 1þ all risk factors 1.18 (0.95; 1.46) –73 (–126; –46)
CVD mortality (438 deaths)
Model 1: Age, sex and health conditions 2.57 (1.81; 3.65)
Model 2: Model 1þbehavioural factors 1.79 (1.24; 2.58) –38 (–76; –19)
Model 3: Model 1þpsychosocial factors 2.38 (1.67; 3.40) –8 (–24; –1)
Model 4: Model 1þphysiological factors 2.33 (1.63; 3.33) –10 (–29; –3)
Model 5: Model 1þ inflammatory markers 2.17 (1.52; 3.09) –18 (–33; –6)
Model 6: Model 1þ all risk factors 1.53 (1.05; 2.23) –55 (–104; –27)
CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio; SES, socio-economic status; D, attenuation, representing the proportion of the SES–
mortality association explained by the risk factor in question. % attenuation is calculated only for statistically significant associations.
Behavioural factors include current smoking, physical activity, alcohol consumption and BMI; psychosocial factors include loneliness score, social network
size, negative and positive support from spouse; physiological factors include systolic and DBP, cholesterol and triglycerides levels; inflammatory markers include
CRP and fibrinogen.
aHR is for the lowest vs highest score.
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cholesterol is less strongly related to all-cause and CVD mor-
tality,45 especially stroke mortality,46 in older age groups. A
recent review, for instance, concluded that low-density-
lipoprotein cholesterol is inversely associated with mortality
risk in people over 60 years.45
It is likely that some of the mediators being compared
(e.g. behavioural and physiological variables) lie at different
points on the same causal pathway rather than being on
separate causal pathways. For example, psychosocial fac-
tors like negative support and loneliness might influence be-
haviours, such as smoking intensity and alcohol
consumption,47 whereas other behaviours such as physical
activity are likely to have a causal effect on physiological in-
dices, such as blood pressure and inflammation.48 On the
other hand, SES may have a direct effect on these factors,
so that it is difficult to establish the order of the effects. In
this study, we decided to test the independent effect of each
set of potential mediating factors and then combine all fac-
tors in a joint model, the overall objective being to examine
the mediating effect of inflammatory markers, if any, in the
association between life-course SES and CVD mortality.
Further, we calculated mediation using the traditional
‘change-in-estimate method’, i.e. the quantification of the
percentage reduction in estimate after controlling for a po-
tential mediating factor. This method, although widely
used,15,25,49 has been criticized.50,51 However, alternative
approaches, such as counterfactual mediation modelling,52–
54 that facilitate disentanglement of the complex pathways
leading from SES to health outcomes, as well as accounting
for some of the limitations of the traditional approach, are
difficult to apply to time to event data with time varying
mediators and complicate interpretation. We attempted to
control for some of the limitations of the traditional
method by controlling not only for exposure-outcome, but
also for mediator-outcome confounding.
After accounting for an array of factors such as health
behaviours, psychosocial conditions, inflammatory and
physiological factors, 50% of the association between life-
course SES and CVD mortality remained unexplained.
Other unmeasured factors that may contribute to this asso-
ciation are the long-term anatomical and physiological ef-
fects of socio-economic disadvantage in utero and in early
childhood, such as intrauterine growth retardation, low
birth weight or epigenetic modifications,13,55,56 exposure
to occupational or environmental risk factors,57 failure to
adhere to medication,58 as well as dietary factors59 and
psychological factors (i.e. anxiety, anger/hostility).60
Strengths and limitations
Our population of individuals in early old age is broadly
representative of the general population of England,
suggesting a high degree of generalisability. The rich phe-
notyping of this cohort also allowed us to examine the con-
tribution of an unusually wide array of factors including
behavioural, psychosocial and physiological factors.
Finally, these factors were assessed on repeat occasions,
thus allowing changes over time to be taken into account.
This study has some limitations that should be considered.
SES in early life was collected retrospectively and thus may
be subject to recall bias, potentially leading to misclassifi-
cation and, if not systematic, to a weakening of associ-
ations with mortality.61 For reasons of study-member
anonymity, users of the ELSA data are only provided with
broad causes of death and we could therefore not examine
specific cardiovascular outcomes separately.
Conclusions
In a population-based cohort of older individuals living in
England, low life-course SES was strongly associated with
a higher risk of CVD and total mortality. Behavioural fac-
tors and inflammatory markers contribute to explain a
relatively large proportion of this association.
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Supplementary data are available at IJE online.
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